Navigation Links
NeoStem Announces Change in Presentation Time for JMP Securities Conference
Date:9/27/2011

NEW YORK, Sept. 27, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced a change in the scheduling of its previously announced presentation at the 6th Annual JMP Securities Healthcare Conference. Dr. Robin L. Smith, Chairman and CEO of NeoStem, and Dr. Andrew L. Pecora, Chief Medical Officer of NeoStem, will now present on Tuesday, September 27th at 3:30 PM. The event takes place at the St. Regis Hotel in New York City at 2 East 55th Street.

About NeoStem, Inc.NeoStem is engaged in the development and manufacturing of cell-based therapies in the U.S. Its January, 2011 acquisition of Progenitor Cell Therapy, and its July 13, 2011 agreement to acquire Amorcyte, Inc. (which is expected to close in the fourth quarter subject to shareholder approval) position NeoStem to achieve its mission of capturing the paradigm shift to cell therapy.

PCT not only gives NeoStem access to a world class contract manufacturing cell therapy company, but provides NeoStem a platform and expertise around the evaluation, development and regulatory requirements necessary to develop autologous, allogeneic, immunomodulatory and vaccine-based therapeutics.

NeoStem also holds the worldwide exclusive license to VSEL™ Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. NeoStem owns 80% of Athelos Corporation, a company developing a T-cell therapeutic with potential in a range of auto-immune conditions such as graft versus host disease, asthma and diabetes. NeoStem's acquisition of Amorcyte, once the transaction is completed, will give the Company a Phase II asset for the
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeoStem Announces Participation in Multiple September Conferences
2. NeoStem Appoints Grant Thornton LLP as New Independent Registered Public Accounting Firm
3. NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter
4. NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
5. NeoStem Announces Proposed Public Offering of Common Stock
6. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
7. NeoStem Announces Agreement with Nankai Hospital in Tianjin to Offer NeoStems Licensed Orthopedic Technology
8. NeoStems Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
9. NeoStems Subsidiary Progenitor Cell Therapy Receives FACT Accreditation for Its New Allendale, New Jersey Manufacturing Facility
10. NeoStem to Present at 10th Annual Needham Healthcare Conference on Tuesday, April 5
11. NeoStem Provides Results for 2010 and an Update on Recent Activities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... plc (NYSE: MNK ) announced today that ... program. The open-ended authorization permits the company to repurchase ... "Funding additional initiatives and seeking attractive ... to pursue a range of focused growth strategies," said ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... focus on Omega-3 therapies for cardiovascular disease and overall health ... Company,s accomplishments in 2014 and its outlook for 2015 from ... Fellow Shareholders, We would like to take this ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
(Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
(Date:1/22/2015)... As interest in the value of spiritual ... worldwide, Rev. Eric J. Hall , president and CEO ... will be the keynote speaker on January 27 at an ... system. , The conference, “Hope and Resilience: Innovative and Interdisciplinary ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Compare-autoinsurance.org has released a ... insured by an auto insurance policy . , Some ... policy. Clients should check the newly released blog post to see ... cars and dangerously damaged vehicles are some of the cars that ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... premier medical and surgical equipment supplier, expands its extensive ... ... (Vocus) April 13, 2009 -- DRE, Inc.—recently named a Company ... new and professionally refurbished healthcare equipment to include the DRE Tempo ...
... researchers has for the first time used tiny molecules called microRNAs to help ... pluripotent, meaning that, like embryonic stem cells , they have the capacity ... ... A team of UCSF researchers has for the first time used ...
... plan in the continental U.S. to offer consumers new ... Imagine being able to talk immediately with a physician who ... questions, make diagnoses and prescribe medications - doing all of ... or a phone. Consumers in Minnesota soon will be ...
... chunk of tissue smaller than the period at the end ... necessary to diagnose cancers and assess their response to treatment, ... In a study to be published April 12 in the ... a specialized machine capable of analyzing whether individual cancer-associated proteins ...
... COVER: "The Mystery of Epilepsy " (p. 38). Newsweek ... a cancerlike sensibility around epilepsy. We cannot usually see our ... for a cure for different cancers with the utmost cultural and ... The toll of epilepsy has been overlooked -- and the research ...
... computer accessories provide infrared heat therapy using infrared heaters in ... pain diagnosis results in cold computer hands and numb cold ... provides warmth and relief. , ... ...
Cached Medicine News:Health News:DRE Medical Equipment Adds Compact Fetal Monitors to Its Product Lineup 2Health News:DRE Medical Equipment Adds Compact Fetal Monitors to Its Product Lineup 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 2Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 4Health News:Blue Cross and Blue Shield of Minnesota and American Well(TM) Join to Bring Online Care to Minnesota 2Health News:Blue Cross and Blue Shield of Minnesota and American Well(TM) Join to Bring Online Care to Minnesota 3Health News:Blue Cross and Blue Shield of Minnesota and American Well(TM) Join to Bring Online Care to Minnesota 4Health News:New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows 2Health News:New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows 3Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 2Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 3Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 4Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 5Health News:Arthritis Hand Pain Relief: Infrared Heat Therapy Ergonomic Computer Workstation 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: